- Main navigation
- CLIC & The CTSA Program
- News & Events
- Groups
- Common Metrics Initiative
- Education & Career Development
- Team Science & Collaboration
- Resources
- CTSA Program Projects & Initiatives
- Contact
- Search
MyCap is a mobile application integrated with REDCap that can be easily configured without programming to collect ongoing participant information and patient-reported outcomes directly from study participants. Study teams can use MyCap to support participant engagement and retention on studies ranging from complex remote/no touch trials, studies using daily medication diaries, or studies seeking
In this webinar, the Vanderbilt Recruitment Innovation Center (RIC) Recruitment Materials Team will share their new Recruitment and Retention Materials Content + Design Toolkit. This toolkit is a resource for research teams to utilize to create participant recruitment and retention materials, as well as materials for clinician awareness/study referrals. It includes: 1) guidelines, recommendations
As recently published, the IREx platform helps operationalize the single IRB (sIRB) mandate (doi:10.1017/cts.2022.376). More than 30 sIRBs are using IREx for over 450 studies with 2600 reliances, and new sIRBs use IREx each year given its utility for lead study teams and coordinating centers. IREx standardizes the sIRB process, automates communications, captures documentation from sites, and
Vanderbilt University Medical Center has competed successfully for a third five-year renewal of its Clinical and Translational Science (UL1) Award by the National Center for Advancing Translational Sciences. Initially funded in 2007, the renewal will provide more than $73 million for another five years to support the Vanderbilt Institute for Clinical and Translational Research (VICTR) and its
Stanford Medicine’s Research Participation services has developed the Participant Engagement Platform (PEP) as a way of offering and managing “honest broker” outreach, such as Direct Email and Epic MyChart. The Research Participation team (honest broker) sends the study invitation to potential participants (identified via EHR cohort search) on behalf of the study team. Only when a potential
This presentation will help answer the question “Should you go online” and other things to consider when deciding if social media will be an option to add to your recruitment plan.
By the end of this presentation, viewers will be able to: 1. Define team science and differentiate team science research from more traditional forms 2. Identify how team science is promoted by the NIH 3. Explain the benefits and shortcomings of teams science research 4. Describe the risks associated with team science models and how to overcome them 5. Describe real-world examples of how team
Clinical research must be modernized. There are increasing demands to have more rapid innovation in order to develop novel treatments more quickly and cost effectively. The challenges that COVID add to the landscape of clinical trials also brings potential for new pathways of clinical trial innovation. Join this discussion to hear about the potential factors driving the decision to use an
We will provide an overview of the project aims and progress so far in building this collaborative set of tools to collect, analyze, share and act on participant feedback. We will describe how the project integrates with into local participant-centered initiatives at collaborating sites.
This webinar will provide an overview of the STELLAR prototype– an interactive web-based system to assess the learning needs of the clinical and translational research workforce, a Self-career Training, Education, Life-long Learning Advancement Resource.
Researchers planning COVID-19 trials with the Trial Innovation Network (TIN) can leverage the N3C to inform their research hypotheses. N3C focuses on aligning its infrastructure so that it can generate efficient and minimally biased results. Part of that infrastructure includes the curation of value sets and phenotype variables relevant to COVID-19, such as ventilator support, ICU use, and
Learn more about obtaining patient-center feedback from underrepresented groups to enhance your research project even in the times of COVID. The CES Team will highlight it’s transition to the use of Zoom technology, how to address issues of tech-equity and literacy, and share lessons learned for effectively facilitating group dialogue in a virtual forum.
This webinar presents scholarly research conducted by the Tufts Center for the Study of Drug Development, Tufts University School of Medicine examining trends in protocol design practice and their impact on clinical trial performance and quality. In particular, the webinar will explore innovative approaches being used to leverage patient and study volunteer input and experience to modify protocol
Vasculitis refers to a group of rare diseases that involve inflammation of blood vessels, which disrupts blood flow and often causes damage to the body’s organs. The cause of most forms of vasculitis remains unknown, and treatments involve the use of strong medications that can have serious side effects. The Vasculitis Clinical Research Consortium (VCRC) is an international, multicenter clinical
Eosinophilic esophagitis, eosinophilic gastritis, eosinophilic gastroenteritis, and eosinophilic colitis are disorders in which a type of immune cell (called eosinophils) builds up in the digestive tract, causing gastrointestinal tissue damage. These disorders are painful, lifelong, and make it hard or impossible for people to eat many or all foods. The Consortium of Eosinophilic Gastrointestinal
The Congenital and Perinatal Infections Consortium (CPIC) is focused on reducing the morbidity and mortality of rare viral infections such as congenital cytomegalovirus (CMV) disease, neonatal herpes simplex virus (HSV) infection, and neonatal viral sepsis caused by enteroviruses (EVs) and the related human parechoviruses (HPeVs). These infections have been grouped together because of their
Implementing your research project within an Electronic Health Record (EHR) system is an exciting but complex endeavor that requires specialized tools and approaches. This talk will unpack what dedicated teams of informaticians have pioneered over the past decade. It will help the researcher understand a path forward for their research protocols. The talk addresses key differences between
The NIA staff will discuss some of the limitations with inclusion of diverse populations observed in clinical research and trials, the role federal science policy is playing in remedying the limitations and promoting more broad and consistent inclusion of communities of color in developing new strategies implemented to enhance inclusion among older persons of color. The NIA team will provide an
At the Vanderbilt Institute for Clinical and Translational Research (VICTR), led by Gordon Bernard, MD, and Consuelo Wilkins, MD, MSCI, we are leading local and national efforts to address urgent and emerging COVID-19 research needs. Nationally, the global pandemic has showcased the ability of the CTSA Hubs to adapt with speed and precision, particularly in the area of informatic and data
INTRODUCTION Under-representation in health-related research is one of a multitude of factors that contribute to health disparities experienced by African American and Latinx communities, and has been brought to the forefront in the context of the COVID-19 pandemic. Barriers to research participation stem from historical social injustices, are multi-faceted and include factors specific to the
Trials Today, a tool from ResearchMatch and Vanderbilt University, offers prospective research participants a quick way to search the thousands of studies available on ClinicalTrials.gov. By answering a few short questions, Trials Today can help find a list of studies that may interest a prospective participant. The Spanish version of Trials Today is now also live.
This webinar will provide an updated overview of Trials Today – an online tool that helps potential participants find studies that are of interest to them and their health condition. Trials Today is a quick and easy way to search the thousands of studies in ClinicalTrials.gov that are recruiting participants.
A collaborative research model was developed and tested to enable regional healthcare systems to join multisite clinical trials emanating from the Clinical and Translational Science Award(CTSA) Trial Innovation Network (TIN) by the Institute of Translational Health Sciences at the University of Washington and the Northwest Participant and Clinical Interactions(NW PCI) Network. The NW PCI is a